Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

NCT06735144 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: FH-006
DRUG: FH-006

Sponsor

Jiangsu HengRui Medicine Co., Ltd.